Skip to main content

Table 2 Demographic and clinical patient characteristics at time point 1

From: The diagnostic accuracy of lung ultrasound to determine PiCCO-derived extravascular lung water in invasively ventilated patients with COVID-19 ARDS

n

27

Admission characteristics

 Age in years, mean (SD)

65 (9.8)

 Male sex, n (%)

12 (44.4)

 BMI in kg/m2, median [IQR]

29 [26, 33]

ARDS classification (Berlin criteria)

 Severe, n (%)

7 (26)

 Moderate, n (%)

20 (74)

 Days since onset of COVID-19 symptoms, mean (SD)

11.88 (5.31)

 SOFA score, median [IQR]

7 [7, 8]

 Charlson comorbidity score, median [IQR]

2 [2, 3.5]

 Cumulative fluid balance (24 h) in liters, median [IQR]

− 0.11 [− 0.59, 0.23)

 IL-6 receptor inhibitors1, n (%)

23 (85)

 Dexamethasone, n (%)

25 (93)

Comorbidities2

 COPD, n (%)

0 (0)

 Heart failure, n (%)

0 (0)

 Renal failure, n (%)

0 (0)

 Myocardial infarction, n (%)

1 (3.7)

Ventilation and gas exchange

 PaO2 in kPa, mean (SD)

9.01 (1.36)

 PaCO2 in kPa, mean (SD)

5.53 (1.04)

 TV/PBW in ml/kg, median [IQR]

6.1 [5.7, 8.6]

 PaO2/FiO2 in mmHg, mean (SD)

136 (40)

 PEEP in cmH2O, median [IQR]

10 [8, 12]

Laboratory measurements

 Hemoglobin in mmol/L, median [IQR]

8.3 [7.7, 8.8]

 Leucocytes × 109/L, median [IQR]

10.8 [8.6, 15.0]

 Thrombocytes × 109/L, median [IQR]

320 [259, 385]

 D-dimer in mg/L, median [IQR]

3.0 [1.6, 5.4]

 Creatinine in micromol/L, median [IQR]

91 [62, 111]

 NTproBNP in pg/ml, median [IQR]

180 [116, 424]

PiCCO measurements

 EVLW in ml, median [IQR]

1026 [843, 1176]

 EVLWi in ml/kg, median [IQR]

14.5 [12.8, 17.1]

 PVPI, median [IQR]

3.2 [2.8, 4.1]

  1. 1Tocilizumab (8 mg/kg single intravenous administration) or sarilumab (400 mg single intravenous administration) administered upon Intensive Care Unit admission; 2Known history of the disease at the moment of randomization
  2. ARDS Acute Respiratory Distress Syndrome, ALT  alanine transaminase, AST  aspartate transaminase, BMI  Body Mass Index, COPD  chronic obstructive pulmonary disease, COVID-19  Coronavirus disease 2019, EVLW(i)  extravascular lung water (index), FiO2  fraction of inspired oxygen, ICU intensive care unit, IL-6 = interleukin-6, IQR  interquartile range, NTproBNP N-terminal pro hormone brain natriuretic peptide, PaO2  partial pressure of oxygen, PCR  Polymerase chain reaction, PEEP  positive end-expiratory pressure, PiCCO  pulse contour cardiac output, PVPI  pulmonary vascular permeability index. QTc  corrected QT interval time, SARS-CoV-2  Severe acute respiratory syndrome coronavirus 2, SD  standard deviation, SOFA  Sequential Organ Failure Assessment, TV/PBW  tidal volume indexed to predicted body weight, PVPI  pulmonary vascular permeability index